

Our study shows that bacterial AMR has been a serious public health threat in the EMR for more than 30 years, with a substantial fatal and non-fatal burden for priority bacterial pathogens and pathogen–drug combinations. The magnitude of this issue, future projects, and the inadequate response capacity in many countries underscore the need for more stringent regional leadership in this field. The insights gained from this study can direct targeted mitigation strategies for individual countries within the region, aiding in resource allocation and funding decisions, and emphasising the need for collaborative multisectoral endeavours among nations to address this issue.
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet